Applied Therapeutics Inc logo

APLT

Applied Therapeutics Inc

$2.05

Earnings Summary

Net Profits
$-29.58Mn

Highlights

Net Profits:

Applied Therapeutics Inc’s net profit fell -14.39% since last year same period to $-29.58Mn in the Q2 2023. On a quarterly growth basis, Applied Therapeutics Inc has generated -214.11% fall in its net profits since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Applied Therapeutics Inc post its latest quarter earnings

EPS Estimate Current Quarter
-0.43
EPS Estimate Current Year
-0.43

Highlights

EPS Estimate Current Quarter:

Applied Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.43 - a 10.42% jump from last quarter’s estimates.

EPS Estimate Current Year:

Applied Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.43.

Key Ratios

Key ratios of the Applied Therapeutics Inc post its Q1 2023 earnings

Return on Assets (ROA)
-0.68
Return on Equity (ROE)
-6.82

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Applied Therapeutics Inc’s return on assets (ROA) stands at -0.68.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Applied Therapeutics Inc’s return on equity (ROE) stands at -6.82.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-08-12
-0.78
-0.96
-23.08%
2022-05-12
-0.83
-0.88
-6.02%
2022-11-09
-0.48
-0.4
16.67%